Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Chengdu Kangnuoxing Biopharma,inc.

Clinical trials sponsored by Chengdu Kangnuoxing Biopharma,inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New shot for teen hay fever? early trial underway Results expected Oct 2026 (estimated)
  • New injection could tame teen hay fever Results expected Dec 2026 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 2 Not yet recruiting 3 Not yet finished but already full! 1
Sort by
  • New biologic stapokibart under safety review for stubborn sinus polyps

    Disease control Ongoing

    This study is testing the safety of a new biologic drug called stapokibart in 600 adults with chronic sinusitis and nasal polyps (CRSwNP). Participants receive the drug as a shot under the skin. The main goal is to track any side effects or serious health events. This is an open-…

    Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Disease control

    Last updated Jun 27, 2026 13:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space